← All trials
NCT05082545
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2021
- Primary completion
- Jul 31, 2025
- Completion date
- Sep 30, 2025
- First posted
- Oct 19, 2021
- Last posted
- Nov 30, 2021
- Enrollment
- 50
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Atridia Pty Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.